LISA PLOCK: Open Payments
NPI 1528056660 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 58 payments from 11 companies in 2025. Trend: 2023 $1,472 · 2024 $1,367 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $201 |
| AstraZeneca Pharmaceuticals LP | 8 | $153 |
| Novo Nordisk Inc | 12 | $151 |
| Lilly USA, LLC | 10 | $144 |
| PFIZER INC. | 5 | $104 |
| SANOFI-AVENTIS U.S. LLC | 3 | $69 |
| Astellas Pharma US Inc | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Radius Health, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: AIRSUPRA, MOUNJARO, NURTEC ODT, VRAYLAR, Wegovy, UBRELVY, TZIELD, Ozempic.
Industry payments across GA — which companies pay providers there.
